CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.64 Cr | ₹0.64 Cr | ₹0.71 Cr | ₹1.02 Cr | ₹1.28 Cr |
What is the latest Contingent Liabilities ratio of CAPLIN POINT LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.64 Cr |
Mar2023 | ₹0.64 Cr |
Mar2022 | ₹0.71 Cr |
Mar2021 | ₹1.02 Cr |
Mar2020 | ₹1.28 Cr |
How is Contingent Liabilities of CAPLIN POINT LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.64 Cr | 0.00 | |
Mar2023 | ₹0.64 Cr | -9.86 | |
Mar2022 | ₹0.71 Cr | -30.39 | |
Mar2021 | ₹1.02 Cr | -20.31 | |
Mar2020 | ₹1.28 Cr | - |
Compare Contingent Liabilities of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹15,073.5 Cr | -4.6% | -8.4% | 35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -4.6% |
-8.4% |
35.4% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses